Myriad Genetics

 

Myriad Genetics tests provides answers to critical questions:
  1. Will I get get the disease? 
  2. How Aggressive is My Disease?
  3. Should I treat the disease?
  4. How should I treat the disease?

BRCA Tests Performed By Myriad

DID YOU KNOW?

Myriad Genetics is the innovator of the BRCA1 and BRCA2 gene
The More Tests Performs, The More Accurate The Results Are
Test With Myriad To Get Access To Myriad’s Private Database

Myriad Genetics 1

Test to avoid unnecessary medication.

Myriad Genetics 2

 

Myriad Genetics 3

Save Money and Improve Your Health

Genetic diagnostic tests are designed to help you make more precise decisions, resulting in more effective treatments, more appropriate screenings, and ultimately improved patient outcomes.

This precision leads to an overall cost savings by either avoiding surgeries, eliminating unnecessary treatment (even chemo), or by providing solutions for  disease prevention or survival.

Why Do We Trust Myriad Genetics?

Proprietary Tools for Accuracy

Pheno® and M-CO™ tool that are used interpretation of genetic tata has published confidence in +/- predictive values: >99%*

Dependable Results

The disease management suggests are proven to reduce mortality. 

Topnotch Lab Analysis

Myriad give you excellent quality. The analytical sensitivity is >99.98%*

Up To Date

Genetic world is changing rapidly. Myriad will give you amended reports when new scientific discoveries are made. Promise for life.

Myriad Genetics Test Offerings

TESTS FOR HEALTHY INDIVIDUAL & HEREDITARY CANCER SCREENING

US FDA APPROVED
BRACAnalysis

BRCA1 AND BRCA2 GENE

BRCA1 GENE
BRCA 2 GENE
RISK OF SECONDARY CANCER FOR BREAST OR OVARIAN CANCER PATIENTS
learn Now
Myrisk

HEREDITARY CANCERS

8 HEREDITARY CANCERS
INCLUDES HEREDITARY BREAST AND OVARIAN CANCER
FIND OUT SECOND CANCER RISK
learn Now

TESTS FOR CANCER TREATMENT

ENDOPREDICT

KNOW IF YOU CAN AVOID CHEMOTHERAPHY

10 YEAR RISK OF RELAPSE
15 YEAR TREATMENT PLAN
BREAST CANCER RECURRENCE
learn Now
PROLARIS

HOW FAST IS YOUR TUMOR GROWING

FIND OUT WHETHER TO TAKE RADIATION
FIND OUT IF YOUR CANCER WILL RETURN
GET A CANCER TREATMENT PLAN
learn Now
US FDA APPROVED
MYCHOICE CDX

OVARIAN CANCER TREATMENT PLAN

ELIGIBILITY FOR PARP INHIBITORS
HRD STATUS
GET GENOMIC INSTABILITY SCORE
learn Now

Explore By Cancer Type

BREAST CANCER

PROSTATE CANCER

OVARIAN CANCER

Need helping selecting the right test for you?

*References: Domcheck S, et al. JAMA 2010; 304(9):967-75. Finch APM, et al. Journal of Clinical Oncology 2014; 32(15): 1547-1553. Metcalfe K, et al. BMJ 2014; 348:g226. Judkins T, et al. BMC Cancer 2015 Apr 2; 15:215. Myriad Genetic Laboratories, Inc. Clinical Quality Assurance Measures. April 2013.